TheraCys Side Effects
Generic name: bcg
Medically reviewed by Drugs.com. Last updated on Jan 31, 2025.
Note: This document provides detailed information about TheraCys Side Effects associated with bcg. Some dosage forms listed on this page may not apply specifically to the brand name TheraCys.
Applies to bcg: intravesical powder for suspension.
Important warnings
This medicine can cause some serious health issues
Intravesical route (powder for suspension; powder for solution)
Bacillus of Calmette and Guérin (BCG) infections have been reported in health care workers and in patients because of exposure to the vaccine during preparation and administration.
Serious and fatal disseminated BCG infections have occurred with intravesical administration.
Manifestations of disseminated infection may not develop for months or years after therapy as BCG may persist in the urinary tract for several months after treatment.
Thera. Cys® and TICE® BCG contain live attenuated mycobacteria and because of the potential risk for transmission, they should be prepared, handled, and disposed of as a biohazard material.
Precautions
While you are being treated with BCG, and for 6 to 12 weeks after you stop treatment with it, avoid contact with people who have tuberculosis. If you think you have been exposed to someone with tuberculosis, tell your doctor.
While you are being treated with BCG and for a few weeks after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval.
Serious side effects of TheraCys
Along with its needed effects, bcg (the active ingredient contained in TheraCys) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor as soon as possible if any of the following side effects occur while taking bcg:
More common side effects
- blood in urine
- fever and chills
- frequent urge to urinate
- increased frequency of urination
- joint pain
- nausea and vomiting
- painful urination (severe or continuing)
Rare side effects
- cough
- skin rash
Other side effects of TheraCys
Some side effects of bcg may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- burning during first urination after treatment
After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, Check with your doctor immediately if you notice the following side effects:
- cough
- fever
For healthcare professionals
Applies to bcg: intravesical powder for reconstitution, percutaneous powder for injection.
Genitourinary adverse events
- Very common (10% or more): Dysuria (60%), increased urgency/frequency (40%), drug induced cystitis (30%), bacterial cystitis (27%), hematuria (27%), pollakiuria
- Common (1% to 10%): Urinary tract infection, urinary incontinence, micturition urgency, urine analysis abnormal, bladder cramps, hemorrhage cystitis, urinary retention
- Uncommon (0.1% to 1%): Bladder constriction, pyuria, ureteric obstruction
- Rare (0.01 to less than 0.1%): Epididymitis
- Very rare (less than 0.01%): Orchitis, balanoposthitis, prostatitis, vulvovaginal discomfort[Ref]
Other
- Very common (10% or more): Malaise/fatigue/lethargy (19%), fever without infection (13%), influenza-like illness, pyrexia, rigors
- Common (1% to 10%): Chills
- Very rare (less than 0.01%): Reiter's syndrome, chest pain, peripheral edema, prostate specific antigen increased, weight decreased, BCG osteomyelitis[Ref]
Nervous system
- Common (1% to 10%): Dizziness, vertigo
- Very rare (less than 0.01%): Dysesthesia, hyperesthesia, paresthesia, somnolence, headache[Ref]
Hematologic
- Common (1% to 10%): Anemia, leukopenia
- Uncommon (0.1% to 1%): Pancytopenia, thrombocytopenia
- Very rare (less than 0.01%): Lymphadenopathy
- Frequency not reported: Axillary or cervical lymphadenopathy, regional suppurative lymphadenitis[Ref]
Gastrointestinal
- Common (1% to 10%): Abdominal pain, nausea, vomiting, diarrhea
- Very rare (less than 0.01%): Dyspepsia, flatulence[Ref]
Immunologic
- Common (1% to 10%): Infection
- Uncommon (0.1% to 1%): Tuberculosis infections
- Very rare (less than 0.01%): Disseminated BCG infection[Ref]
Dermatologic
- Common (1% to 10%): Skin rash, sweats
- Uncommon (0.1% to 1%): Rashes, eruptions and exanthema not otherwise classified
- Very rare (less than 0.01%): Lupus vulgaris, alopecia, hyperhidrosis, granuloma[Ref]
Respiratory
- Common (1% to 10%): Pneumonitis
- Rare (0.01% to 0.1%): Cough
- Very rare (less than 0.01%): Pharyngitis, bronchitis, dyspnea, rhinitis[Ref]
Renal
- Very rare (less than 0.01%): Renal failure acute[Ref]
Musculoskeletal
Hypersensitivity
- Common (1% to 10%): Allergic symptoms[Ref]
Hepatic
- Uncommon (0.1% to 1%): Hepatitis, hepatic enzyme increased[Ref]
Cardiovascular
- Very rare (less than 0.01%): Hypotension[Ref]
Psychiatric
- Very rare (less than 0.01%): Confusional state[Ref]
Metabolic
- Very rare (less than 0.01%): Anorexia[Ref]
Ocular
- Very rare (less than 0.01%): Conjunctivitis[Ref]
Local
- Frequency not reported: Injection site reactions: Induration, pustule formation, ulceration, caseous lesions, purulent draining, tenderness, itching, papules[Ref]
See also:
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Adstiladrin
Adstiladrin (nadofaragene firadenovec-vncg) is a gene therapy used to treat high-risk Bacillus ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amtagvi
Amtagvi (lifileucel) is a type of medicine called “tumor-derived autologous T cell immunotherapy” th ...
Anktiva
Anktiva (N-803) is used to treat specific types of bladder cancer. It is FDA-approved to be used ...
References
1. "Product Information. Tice BCG Live (for intravesical use) (BCG)." Organon
2. Cerner Multum, Inc. "UK Summary of Product Characteristics."
3. Cerner Multum, Inc. "Australian Product Information."
4. "Product Information. BCG Vaccine (BCG vaccine)." Organon Pharmaceuticals
Frequently asked questions
More about TheraCys (bcg)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
TheraCys side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.